Sly Saint
Senior Member (Voting Rights)
The goal of making science more transparent—sharing data, posting results on trial registries, use of preprint servers, and open access publishing—may enhance scientific discovery and improve individual and population health, but it also comes with substantial challenges in an era of politicized science, enhanced skepticism, and the ubiquitous world of social media.
The recent announcement by the Trump administration of plans to proceed with an updated version of the proposed rule “Strengthening Transparency in Regulatory Science,”1 stipulating that all underlying data from studies that underpin public health regulations from the US Environmental Protection Agency (EPA) must be made publicly available so that those data can be independently validated, epitomizes some of these challenges.2,3
According to EPA Administrator Andrew Wheeler: “Good science is science that can be replicated and independently validated, science that can hold up to scrutiny. That is why we’re moving forward to ensure that the science supporting agency decisions is transparent and available for evaluation by the public and stakeholders.”3
Above all, the scientific process—including original research and reanalysis of shared data—must prevail, and the inherent search for evidence, facts, and truth must not be compromised by special interests, coercive influences, or politicized perspectives. There are no simple answers, just words of caution and concern.
(This Editorial is available for online commenting.)
full editorial here:
https://jamanetwork.com/journals/jama/fullarticle/2756117
(note, article was retweeted by MS who is now 65th President and Chairman of the Board of the Academy of Consultation-Liaison Psychiatry)